Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HERBALIFE LTD. Director's Dealing 2018

Mar 6, 2018

32337_dirs_2018-03-06_d8cde53f-0b6d-438b-a342-36160b1844e1.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HERBALIFE LTD. (HLF)
CIK: 0001180262
Period of Report: 2018-03-02

Reporting Person: Hoffman Alan L (EVP, Global Corporate Affairs)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-03-02 Common Stock M 67243 $50.98 Acquired 69125 Direct
2018-03-02 Common Stock D 36192 $94.72 Disposed 32933 Direct
2018-03-02 Common Stock F 15396 $94.72 Disposed 17537 Direct
2018-03-02 Common Stock M 31219 $50.98 Acquired 48756 Direct
2018-03-02 Common Stock D 16803 $94.72 Disposed 31953 Direct
2018-03-02 Common Stock F 5578 $94.72 Disposed 26375 Direct
2018-03-02 Common Stock M 4590 $57.19 Acquired 30965 Direct
2018-03-02 Common Stock D 2772 $94.72 Disposed 28193 Direct
2018-03-02 Common Stock F 902 $94.72 Disposed 27291 Direct
2018-03-02 Common Stock M 4367 $62.51 Acquired 31658 Direct
2018-03-02 Common Stock D 2882 $94.72 Disposed 28776 Direct
2018-03-02 Common Stock F 737 $94.72 Disposed 28039 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2018-03-02 Stock Appreciation Rights $50.98 M 67243 Disposed 2024-09-01 Common Stock (67243) Direct
2018-03-02 Stock Appreciation Rights $50.98 M 31219 Disposed 2024-09-01 Common Stock (31219) Direct
2018-03-02 Stock Appreciation Rights $57.19 M 4590 Disposed 2027-02-27 Common Stock (4590) Direct
2018-03-02 Stock Appreciation Rights $62.51 M 4367 Disposed 2026-05-09 Common Stock (4367) Direct

Footnotes

F1: The reporting person received 15,655 shares of common stock upon the net exercise of the 67,243 SARs. The reporting person forfeited 36,192 shares of common stock underlying the SARs in payment of the exercise price and 15,396 shares of common stock underlying the SARs to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on March 2, 2018 of $94.72.

F2: The reporting person received 8,838 shares of common stock upon the net exercise of the 31,219 SARs. The reporting person forfeited 16,803 shares of common stock underlying the SARs in payment of the exercise price and 5,578 shares of common stock underlying the SARs to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on March 2, 2018 of $94.72.

F3: The reporting person received 916 shares of common stock upon the net exercise of the 4,590 SARs. The reporting person forfeited 2,772 shares of common stock underlying SARs in payment of the exercise price and 902 shares of common stock underlying the SARs to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on March 2, 2018 of $94.72.

F4: The reporting person received 748 shares of common stock upon the net exercise of the 4,367 SARs. The reporting person forfeited 2,882 shares of common stock underlying SARs in payment of the exercise price and 737 shares of common stock underlying the SARs to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on March 2, 2018 of $94.72.

F5: Consists of 22,951 stock appreciation rights granted under the Herbalife Ltd. 2014 Stock Incentive Plan, of which 20% vested on February 27, 2018, 20% will vest on February 27, 2019, and the remaining 60% will vest on February 27, 2020.

F6: Consists of 21,834 stock appreciation rights granted under the Herbalife Ltd. 2014 Stock Incentive Plan, of which 20% vested on May 9, 2017, 20% will vest on May 9, 2018, and the remaining 60% will vest on May 9, 2019.